Working… Menu

Neo-adjuvant Trial With AZD9291 in EGFRm+ Stage IIIA/B NSCLC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02824952
Recruitment Status : Recruiting
First Posted : July 7, 2016
Last Update Posted : June 9, 2020
Information provided by (Responsible Party):
Dr. Nir Peled MD, PhD, Soroka University Medical Center

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2022
Estimated Study Completion Date : December 2022